Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

3.61USD
4:35pm BST
Change (% chg)

$-0.04 (-1.10%)
Prev Close
$3.65
Open
$3.73
Day's High
$3.77
Day's Low
$3.57
Volume
22,597
Avg. Vol
73,696
52-wk High
$14.52
52-wk Low
$3.20

About

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. The Company has developed a platform that enables it to identify cancer targets, find and genetically engineer TCR,... (more)

Overall

Beta: 1.62
Market Cap(Mil.): $382.25
Shares Outstanding(Mil.): 104.73
Dividend: --
Yield (%): --

Financials

  ADAP.OQ Industry Sector
P/E (TTM): -- 98.06 34.39
EPS (TTM): -1.02 -- --
ROI: -46.22 7.59 12.67
ROE: -49.74 8.10 17.18

Earnings vs. Estimates